Ramya S. Kuna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramya S. Kuna has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Christian M. Metallo
Salk Institute for Biological Studies, La Jolla, CA, USA
45 shared publications - Reuben J. Shaw
Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA
45 shared publications - Thekla Cordes
Department of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany
45 shared publications - Alexandra Kuhlmann-Hogan
NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California
44 shared publications - Anna-Maria Globig
Allen Institute for Immunology , Seattle, WA
44 shared publications - Camila Robles-Oteíza
Yale School of Medicine 1 Department of Immunobiology New Haven, CT
44 shared publications
Latest Publications
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S1: Myeloid cell regulation during lung tumorigenesis.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S1: Myeloid cell regulation during lung tumorigenesis.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S6 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S6: Single cell analysis of tumorigenesis in humans reveals rewired LUAD patient macrophage lipid and mitochondrial metabolism.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S6: Single cell analysis of tumorigenesis in humans reveals rewired LUAD patient macrophage lipid and mitochondrial metabolism.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S5 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S5: PPARγ Antagonist GW9662 modulates induces tumor regression and modulates the TME.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S5: PPARγ Antagonist GW9662 modulates induces tumor regression and modulates the TME.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S5 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S5: PPARγ Antagonist GW9662 modulates induces tumor regression and modulates the TME.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S5: PPARγ Antagonist GW9662 modulates induces tumor regression and modulates the TME.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S2: Innate immune cells are regulated by GM-CSF and contributes to tumorigenesis.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S2: Innate immune cells are regulated by GM-CSF and contributes to tumorigenesis.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S4 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S4: Deficiency of PPARγ in CSF1R- or CD11c-expressing cells suppresses tumor growth.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S4: Deficiency of PPARγ in CSF1R- or CD11c-expressing cells suppresses tumor growth.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S2: Innate immune cells are regulated by GM-CSF and contributes to tumorigenesis.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S2: Innate immune cells are regulated by GM-CSF and contributes to tumorigenesis.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S4 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S4: Deficiency of PPARγ in CSF1R- or CD11c-expressing cells suppresses tumor growth.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S4: Deficiency of PPARγ in CSF1R- or CD11c-expressing cells suppresses tumor growth.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S9 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S9: Statins inhibit EGFRmutant tumor cell growth and oncogenic signaling.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S9: Statins inhibit EGFRmutant tumor cell growth and oncogenic signaling.
- Open Access
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Figure S7 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S7: PPARγ antagonist GW9662 rewires Alveolar macrophage metabolism within the TME.
- 1 May 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth
Figure S7: PPARγ antagonist GW9662 rewires Alveolar macrophage metabolism within the TME.